Figure 7.
Significant associations of metabolite levels determined by HR-MAS NMR with clinicopathological factors in human breast cancer. 1 Choi et al. 2012 [47]; 2 Cao et al. 2014 [96]; 3 Moestue et al. 2010 [40]; 4 Cheng et al. 1998 [49]; 5 Giskeödegård et al. 2012 [85]; 6 Cao et al. 2012b [38]; 7 Cao et al. 2012a [37].
